Silexion Therapeutics Corp

Penny Stocks Biotech Stocks Healthcare Stocks

$1.61

+0.10 (+6.62%)

As of Feb 8, 2:32 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +2,150.9% upside

Low Target $26.81

Average Target $36.24

High Target $52.45

Current Price $1.61

Current
$1.61

Target
$36.24

$26.81 $36.24 avg $52.45

Scenario Analysis

Bear Case

$26.81

1,565.2%

Low target

Base Case

$36.24

+2,150.9%

Avg target

Bull Case

$52.45

+3,157.8%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$41.75

-96.1% from high

52-Week Low

$16.04

+-90.0% from low

Target vs 52W High

$36.24

-13.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%